Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Fluoroquinolones in the management of community-acquired pneumonia.

Albertson TE, Dean NC, El Solh AA, Gotfried MH, Kaplan C, Niederman MS.

Int J Clin Pract. 2010 Feb;64(3):378-88. doi: 10.1111/j.1742-1241.2009.02239.x. Review.

PMID:
20456176
2.

Fluoroquinolones in the management of community-acquired pneumonia in primary care.

Wispelwey B, Schafer KR.

Expert Rev Anti Infect Ther. 2010 Nov;8(11):1259-71. doi: 10.1586/eri.10.110. Review.

PMID:
21073291
4.

Gemifloxacin for community-acquired pneumonia.

Lode HM, Schmidt-Ionas M, Stahlmann R.

Expert Opin Investig Drugs. 2008 May;17(5):779-86. doi: 10.1517/13543784.17.5.779 . Review.

PMID:
18447602
5.

Community acquired pneumonia.

Loeb M.

Clin Evid. 2002 Jun;(7):1358-68. Review. No abstract available. Update in: Clin Evid. 2002 Dec;(8):1546-57.

PMID:
12230751
7.

Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.

Yoo BK, Triller DM, Yong CS, Lodise TP.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1226-35. Epub 2004 Jun 8. Review.

PMID:
15187209
8.

Doxycycline for community-acquired pneumonia.

Cunha BA.

Clin Infect Dis. 2003 Sep 15;37(6):870. No abstract available.

PMID:
12955665
9.

Fluoroquinolones should not be the first-line antibiotics to treat community-acquired pneumonia in areas of tuberculosis endemicity.

Singh A.

Clin Infect Dis. 2007 Jul 1;45(1):133; author reply 134-5. No abstract available.

PMID:
17554716
10.

Role of gemifloxacin in community-acquired pneumonia.

Tillotson GS.

Expert Rev Anti Infect Ther. 2008 Aug;6(4):405-18. doi: 10.1586/14787210.6.4.405. Review.

PMID:
18662107
11.

The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumonia.

Ferrer M, Menendez R, Amaro R, Torres A.

Clin Chest Med. 2011 Sep;32(3):491-505. doi: 10.1016/j.ccm.2011.06.002. Review.

PMID:
21867818
12.

Worldwide guidelines for respiratory tract infections: community-acquired pneumonia.

Dalhoff K.

Int J Antimicrob Agents. 2001;18 Suppl 1:S39-44. Review.

PMID:
11574194
13.

Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.

Segreti J, House HR, Siegel RE.

Am J Med. 2005 Jul;118 Suppl 7A:21S-28S. Review.

PMID:
15993674
14.

Guidelines for community-acquired pneumonia in the ICU.

Wilkinson M, Woodhead MA.

Curr Opin Crit Care. 2004 Feb;10(1):59-64. Review.

PMID:
15166851
15.

Community acquired bacterial pneumonia.

Anevlavis S, Bouros D.

Expert Opin Pharmacother. 2010 Feb;11(3):361-74. doi: 10.1517/14656560903508770. Review.

PMID:
20085502
16.

The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.

Nakamura S, Yanagihara K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Senjyu H, Saito A, Kohno S.

J Infect. 2009 Sep;59(3):222-4. doi: 10.1016/j.jinf.2009.06.008. Epub 2009 Jun 21. No abstract available.

PMID:
19592113
17.

Monotherapy or combination therapy for hospitalized patients with community-acquired pneumonia: not yet the end of the story?

Laterre PF.

Clin Infect Dis. 2008 May 15;46(10):1510-2. doi: 10.1086/587666. No abstract available.

PMID:
18419483
18.

Community-acquired pneumonia: the U.S. perspective.

Niederman MS.

Semin Respir Crit Care Med. 2009 Apr;30(2):179-88. doi: 10.1055/s-0029-1202937. Epub 2009 Mar 18. Review.

PMID:
19296418
19.

Community-acquired pneumonia: new guidelines for management.

File TJ Jr.

Curr Opin Infect Dis. 2001 Apr;14(2):161-4. Review. No abstract available.

PMID:
11979127
20.

Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.

Niven DJ, Laupland KB.

Expert Rev Anti Infect Ther. 2009 Feb;7(1):69-81. doi: 10.1586/14787210.7.1.69. Review.

PMID:
19622058

Supplemental Content

Support Center